Bing

SEARCH HISTORY

NEW YORK (TheStreet) -- Cytori Therapeutics (CYTX - Get Report) shares are up 19.83% to $1.39 in afternoon trading on Monday after the company said that Chinese regulators approved its regenerative cell technology. Lorem Vascular has the rights to …
The Street · 4/6/2015
One stock that might be an intriguing choice for investors right now is Cytori Therapeutics, Inc. (CYTX). This is because this security in the pharmaceutical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks ...
Yahoo Finance · 3/30/2015
One stock that might be an intriguing choice for investors right now is Cytori Therapeutics, Inc. ( CYTX). This is because this security in the pharmaceutical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks ...
NASDAQ · 3/30/2015
More from Bing News
CYTX opened @.71¢ so I thought I missed it for $5. Well it... Close to the same as yours Money picked this up in early Dec for 0.42 and sold at 1.36 made even more with the U.S vs Can exchange. Was...
Stockhouse · 5/27/2015
Also today, Hal Mintz’s Sabby Capital more than quadrupled its exposure to Cytori Therapeutics Inc (NASDAQ:CYTX), and now owns 8.39 million shares of Common Stock, which represent 9.99% of the company’s outstanding stock. Aegerion …
INSIDER MONKEY · 10/15/2014
Cytori Therapeutics (NASDAQ: CYTX) stock price has been down relentlessly throughout the majority of 2014, a steep decline attributable to multiple factors including the clinical enrollment hold placed on its ATHENA and ATHENA II trials, ongoing cash ...
Seeking Alpha · 11/26/2014
Viggle Inc. (VGGL) of the Services sector is down -10.73% (change from open -9.83%) this morning trading at a volume of 206,156 shares and price of $1.8. Viggle Inc. (VGGL)’s weekly performance is 44.29% and compared to their 52 week low, they are …
wallstreetscope.com · 4/17/2015
Cytori Therapeutics (NASDAQ:CYTX) saw a significant decline in short interest in the month of April ... has a one year low of $0.360 and a one year high of $2.550. The stock has a 50-day moving average of $1.1 and a 200-day moving average of $0.6. The ...
Mideast Times · 4/27/2015
In fact, it would take more than three weeks to buy back all of these shorted shares, at CYTX's typical daily trading volume. Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations ...
Schaeffer's Investment Research · 2/26/2015
uniQure N.V. (Nasdaq: QURE) 45.7% HIGHER; Bristol-Myers Squibb (NYSE: BMY) and uniQure N.V. (Nasdaq: QURE) announced an agreement that provides Bristol-Myers Squibb with exclusive access to uniQures gene therapy technology platform for …
StreetInsider · 4/6/2015